CNY 18.67
(3.49%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 991.26 Million | 789.24 Million | 894.14 Million | 405.31 Million | 1.16 Billion | -346 Million |
Net Income | 726.58 Million | 692.25 Million | 514.99 Million | 371.53 Million | 262.6 Million | 257.37 Million |
Depreciation & Amortization | 449.11 Million | 520.08 Million | 455.68 Million | 433.8 Million | 235.89 Million | 212.44 Million |
Deferred income taxes | -166.48 Thousand | -13.76 Million | -15.78 Million | -27.81 Million | 1.95 Million | -4.12 Million |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -289.03 Million | -410.58 Million | -157.87 Million | -495.54 Million | 590.17 Million | -873.39 Million |
Other non-cash items | 1.29 Billion | -12.51 Million | 81.34 Million | 95.51 Million | 75.71 Million | 57.56 Million |
Investing Cash Flow | -510.79 Million | -106.34 Million | -3.3 Billion | -421.35 Million | -558.31 Million | -253.85 Million |
Investments in PPE | -1.01 Billion | -681.59 Million | -704 Million | -417.15 Million | -592.64 Million | -369.43 Million |
Acquisitions | 3.25 Million | 696.47 Thousand | 1.44 Million | 992.64 Thousand | 4.2 Million | 7.25 Million |
Investment purchases | -1.6 Billion | -3.2 Billion | -2.6 Billion | - | -4.2 Million | - |
Sales/Maturities of investments | 2.1 Billion | 3.77 Billion | -1.44 Million | - | 30.13 Million | 108.31 Million |
Other Investing Activities | 511.21 Million | 0.17 | 1.44 Million | -5.19 Million | 4.2 Million | 7.25 Million |
Financing Cash Flow | -79.76 Million | -36.78 Million | 3.44 Billion | -56.08 Million | 149.4 Million | -134.67 Million |
Debt repayment | -151.5 Million | -170.5 Million | -230.5 Million | -413.2 Million | -585.66 Million | -667.5 Million |
Dividends payments | -69.7 Million | -59.18 Million | -51.9 Million | -45.82 Million | -45.82 Million | -71.87 Million |
Common Stock Repurchased | - | 1 Million | 1.19 Million | - | - | - |
Common Stock Issuance | - | -1 Million | -1.19 Million | - | - | - |
Other Financing Activities | 141.44 Million | 199.68 Million | 3.73 Billion | 421.53 Million | 806.51 Million | 604.69 Million |
Accounts receivables | -194.95 Million | -266.85 Million | -927.06 Million | -794.49 Million | 320.2 Million | -650 Million |
Accounts payables | 27.32 Million | 190.71 Million | 901.04 Million | 500.72 Million | 214.67 Million | -68.13 Million |
Inventory | -121.4 Million | -320.68 Million | -116.07 Million | -171.46 Million | 53.34 Million | -151.13 Million |
Other working capital | 27.16 Million | -13.76 Million | -15.78 Million | -30.31 Million | 1.95 Million | -722.26 Million |
Cash at beginning of period | 3.5 Billion | 2.84 Billion | 1.81 Billion | 1.89 Billion | 1.13 Billion | 1.86 Billion |
Cash at end of period | 3.9 Billion | 3.5 Billion | 2.84 Billion | 1.81 Billion | 1.89 Billion | 1.13 Billion |
Capital Expenditure | -1.01 Billion | -681.59 Million | -704 Million | -417.15 Million | -592.64 Million | -369.43 Million |
Effect of forex changes on cash | 1.9 Million | 7.81 Million | -3.84 Million | -7.61 Million | 1.5 Million | 4.95 Million |
Net cash flow / Change in cash | 402.6 Million | 653.91 Million | 1.03 Billion | -79.73 Million | 756.99 Million | -729.59 Million |
Free Cash Flow | -22.79 Million | 107.64 Million | 190.14 Million | -11.84 Million | 571.74 Million | -715.44 Million |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 159.16 Million | 209.38 Million | 260.34 Million | 130.39 Million | 726.58 Million | 146.54 Million |
Depreciation & Amortization | - | 141.3 Million | 141.3 Million | 127.76 Million | 449.11 Million | -224.76 Million |
Deferred income taxes | - | -4.13 Million | - | - | -166.48 Thousand | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | -316.36 Million | -289.03 Million | 763.66 Million |
Other non-cash items | 470.85 Million | 316.11 Million | -453.81 Million | 56.53 Million | 1.29 Billion | -473.07 Million |
Investing Cash Flow | -869.52 Million | -273.72 Million | 147.92 Million | 360.22 Million | -510.79 Million | 90.9 Million |
Investments in PPE | -246.46 Million | -269.02 Million | -152.17 Million | -432.53 Million | -1.01 Billion | -218.27 Million |
Acquisitions | 67.27 Thousand | 303.05 Thousand | 99.25 Thousand | 718.47 Thousand | 3.25 Million | 248.42 Thousand |
Investment purchases | -25 Million | -305 Million | - | -1.3 Billion | -1.6 Billion | 1.68 Million |
Sales/Maturities of investments | -598.12 Million | 300 Million | 300 Million | 2.09 Billion | 2.1 Billion | 307.24 Million |
Other Investing Activities | - | -304.69 Million | 301.97 Million | -1.00 | 511.21 Million | 0.08 |
Financing Cash Flow | 27.08 Million | -203.69 Million | -5.71 Million | 58.43 Million | -79.76 Million | 17.23 Million |
Debt repayment | - | - | - | -6.5 Million | -151.5 Million | - |
Dividends payments | - | -218.32 Million | -285.17 Thousand | -69.7 Million | -69.7 Million | -69.7 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | 27.08 Million | 25.52 Million | -5.71 Million | 134.63 Million | 141.44 Million | 17.48 Million |
Accounts receivables | - | - | - | -194.95 Million | -194.95 Million | 754.89 Million |
Accounts payables | - | - | - | - | 27.32 Million | - |
Inventory | - | - | - | -121.4 Million | -121.4 Million | 8.76 Million |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | 3.75 Billion | 3.85 Billion | 3.9 Billion | 3.48 Billion | 3.5 Billion | 3.16 Billion |
Cash at end of period | 3.54 Billion | 3.75 Billion | 3.85 Billion | 3.9 Billion | 3.9 Billion | 3.48 Billion |
Capital Expenditure | -246.46 Million | -269.02 Million | -152.17 Million | -432.53 Million | -1.01 Billion | -218.27 Million |
Effect of forex changes on cash | - | -211.81 Thousand | -309.37 Thousand | -961.22 Thousand | 1.9 Million | -973.69 Thousand |
Net cash flow / Change in cash | -213.61 Million | -97.56 Million | -51.58 Million | 416.03 Million | 402.6 Million | 319.52 Million |
Free Cash Flow | 383.54 Million | 111.03 Million | -345.65 Million | -434.19 Million | -22.79 Million | -5.91 Million |
ULTP
GULFNAV
AARTIPHARM
200725
SQI
300347